GAGE2C: A Potential Drug Target and Biomarker for Gout and other Chronic Inflammatory Diseases

Target Name: GAGE2C

NCBI ID: G2574

GAGE2C

GAGE2C: A Potential Drug Target and Biomarker for Gout and other Chronic Inflammatory Diseases

Gout is a chronic inflammatory disease that affects the joints, causing severe pain, inflammation, and joint damage. It is characterized by the buildup of uric acid crystals in the joints, which can cause damage to the connective tissue and lead to chronic joint pain and stiffness. GAGE2C is a protein that has been identified as a potential drug target and biomarker for gout and other chronic inflammatory diseases.

GAGE2C is a protein that is expressed in the liver, and it has been shown to play a role in the regulation of uric acid levels in the body. It is made up of two subunits, GAGE2 and GAGE3, which work together to regulate the levels of uric acid in the body. GAGE2 is the N-terminus of the protein, while GAGE3 is the C-terminus.

Research has shown that GAGE2 is a key regulator of uric acid metabolism, and that it plays a role in the regulation of not only uric acid levels, but also the levels of other enzymes that are involved in the metabolism of uric acid. GAGE2 has been shown to interact with a variety of different proteins, including UGT1A1, UGT2B6, and CYP2C9, and it has been shown to regulate the activity of these enzymes.

GAGE2 has also been shown to play a role in the regulation of inflammation. It has been shown to interact with various cytokines, including TNF-alpha, IL-1, and IL-6. These cytokines are involved in the regulation of immune responses and have been shown to play a role in the development of inflammatory diseases, including gout.

GAGE2 has also been shown to play a role in the regulation of pain. It has been shown to interact with FAAORK1, a protein that is involved in the regulation of pain. FAAORK1 has been shown to play a role in the regulation of pain perception and has been shown to interact with GAGE2 in order to regulate the activity of GAGE2.

GAGE2 has also been shown to play a role in the regulation of cellular signaling pathways. It has been shown to interact with various signaling pathways, including the PI3K/Akt signaling pathway and the TGF-beta signaling pathway. These signaling pathways are involved in the regulation of cellular processes that are important for the development and progression of a variety of diseases, including gout.

GAGE2 has also been shown to play a role in the regulation of inflammation and pain. It has been shown to interact with various cytokines, including TNF-alpha, IL-1, and IL-6. These cytokines are involved in the regulation of immune responses and have been shown to play a role in the development of inflammatory diseases, including gout. It has also been shown to interact with FAAORK1, a protein that is involved in the regulation of pain. FAAORK1 has been shown to play a role in the regulation of pain perception and has been shown to interact with GAGE2 in order to regulate the activity of GAGE2.

GAGE2 has also been shown to play a role in the regulation of cellular signaling pathways. It has been shown to interact with various signaling pathways, including the PI3K/Akt signaling pathway and the TGF-beta signaling pathway. These signaling pathways are involved in the regulation of cellular processes that are important for the development and progression of a variety of diseases, including gout.

GAGE2 has also been shown to play a role in the regulation of inflammation and pain. It has been shown to interact with various cytokines, including TNF-alpha, IL-1, and IL-6. These cytokines are involved in the regulation of immune responses and have been shown to play a role in the development of inflammatory diseases, including gout. It has also been shown to interact with FAAORK1, a protein that is involved in the regulation of pain. FAAORK1 has been shown to play a role in the regulation of pain perception and has been shown to interact with GAGE2 in order to regulate the activity of GAGE2.

In conclusion, GAGE2C is a protein that has been shown to play a

Protein Name: G Antigen 2C

Functions: Antigen, recognized on melanoma by autologous cytolytic T-lymphocytes

The "GAGE2C Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about GAGE2C comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets